Strain Name: |
STOCK Myo5ad Ds/J |
|---|---|
Stock Number: |
000390 |
Availability: | Repository-Cryopreserved |
General Terms and Conditions |
| Genes & Alleles | Ds; Myo5a; Myo5ad; |
Type JAX® GEMM® Strain - Mutant Stock Additional information on JAX® GEMM® Strains. Species laboratory mouse Generation F23+29p Strain Development
The mutation disorganization (Ds) arose spontaneously in the incipient inbred strain DA/Hu at F22 around 1957 at The Jackson Laboratory. The first mutant identified was a female that was then bred to her wild type brother and their mutant daughter was backcrossed to her wild type father. This pair bore mutant offspring and two females were outcrossed to DBA/1J. The mutant was then continually backcrossed to DBA/1J to generation N11 and then sister x brother bred, always mating a mutant phenotype to a wild type to F25. The penatrance of this mutation varied on different backgrounds. In 1974 the strain was outcrossed to 129/TerSv once (N1) and then sister x brother bred to F23. The strain was then referred to as a STOCK and inbreeding continued. It was cryopreserved in 1992 by mating a +/? females with Ds/+ to males at generation F23+F28.
| Allele Symbol | Ds | ||
|---|---|---|---|
| Allele Name | disorganization | ||
| Strain of Origin | DA/Hu | ||
| General Note |
The Ds mutation arose spontaneously in the inbred DA/Hu strain at The Jackson Laboratory. Ds disrupts the orderly processes of development. Most homozygotes probably die in utero after implantation and before term (J:13012), but some may possibly be normal and viable (J:15079). Heterozygotes may be normal, may deviate slightly, or may be monstrous individuals with multiple defects (J:13012, J:2436). Two genetics studies showed that Ds is a completely dominant gain-of-function trait (J:1477). Byusing flanking genetic markers in intercrosses between Ds/+ heterozygotes, Crosby et al. showed that homozygous Ds/Ds mice occur in the expected Mendelian frequency and that the type or severity of birth defect did not differ noticeably between affectedDs/Ds homozygotes and Ds/+ heterozygotes. In addition, they took advantage of non-disjunction in mice heterozygotes for different Robertsonian translocations to determine whether trisomic +/+/Ds mice showed defects characteristic of those found in other mice with the Disorganization defect. Discovery of Ds-specific defects in several trisomic fetuses shows that Ds is probably a gain-of-function mutation. A statistical analysis of the number of developmental independent birth defects in affected micewith the Disorganization mutation supports a two-hit model. Because of low penetrance, most mice with Disorganization are not obviously affected. However, mice with several independent defects are found (J:2436). Crosby et al (J:39902) showed that thefrequency distribution of mice with 0, 1, 2, 3, .., defects fits a Poisson model, suggesting that inheritance of Disorganization predisposes mice to birth defects, but that other secondary somatic events must occur to determine the location and type of birth defect. The nature of this second-hit, whether genetic or epigenetic, remains to be determined. Two groups mapped Gata4 near Ds on Chromosome 14 (J:26107, J:25626). White et al. propose that Gata4 is a candidate gene for Ds. Gata4 is on the Ds contig (N. Abbadi and J. Nadeau, unpublished), providing additional evidence that it is a candidate. A review has been published that compares the variety of birth defects found in mice with the Disorganization mutation and with infants with similar birth defects in humans (J:44298). The possibility of a homolog of Disorganization in humans has been the subject of considerable speculation, especially given the very similar nature of some of the birth defects in the two cases. This review summarizes the cases and evaluates the evidence. | ||
| Molecular Note | Ds is a gain-of-function mutation. [MGI Ref ID J:1477] | ||
| Allele Symbol | Myo5ad | ||
| Allele Name | dilute | ||
| Common Name(s) | d; dv; maltese dilution; | ||
| Strain of Origin | old mutant of the mouse fancy | ||
| Gene Symbol and Name | Myo5a, myosin Va | ||
| Chromosome | 9 | ||
| Gene Common Name(s) | 9630007J19Rik; AI413174; AI661011; D; Dbv; Dop; GS1; MVa; MYH12; MYO5; MYR12; Myo5; MyoVA; RIKEN cDNA 9630007J19 gene; d; dilute; expressed sequence AI413174; expressed sequence AI661011; flail; flailer; flr; myosin V; nmf244; | ||
| General Note |
Mutations at the Myo5a locus lighten coat color through an abnormal morphology of melanocytes that causes uneven pigmentation of the hair shaft (J:11005). Most of these mutations also cause severe neurological defects; in some mutant forms, these defectslead to early death (J:12978), while in others life span is normal, but convulsions and loss of equilibrium occur after about four months of age (J:16915). Maltese dilution, as this mutation was originally called, is an old mutation of the mouse fancy. The blue-gray color of the hair produced by this mutation in nonagouti (a/a) mice is caused by clumping of the melanin pigment into a few large masses (J:12958). The melanocytes are misshapen, with fewer and thinner dendritic processes than wild-type melanocytes, and melanin granules are largely clumped around the nucleus (J:12970). Incorporation of tyrosine into melanin proceeds at a normal rate (J:12173), and the fine structure of the melanin granules is normal (J:5346). Cultured primary melanocytesfrom dilute homozygotes are normal in morphology but display clustering of melanosomes (J:37976). Griscelli disease (Chediak-Higashi-like syndrome, OMIM 214450) is a human autosomal recessive disorder whose symptoms include pigment dilution, immunodeficiency, and acute lethal lymphocyte and macrophage activation. Melanocyte malformation is characteristic of the pigment abnormality. The immunological abnormality includes absence of cutaneous hypersensitivity and impaired function of natural-killer cells. Griscelli disease resembles the dilute-lethal mouse mutant, except for the neurological disorder in the mouse. The locus for Griscelli disease colocalizes with the locus for myosin Va, which is mutated in at least some Griscelli patients. Griscelli disease is thus the homolog of mouse Maltese dilution (J:41253). The original Myo5ad mutation which identified the locuswas caused by insertion of an ecotropic murine leukemia virus (see Emv3) (J:6844, J:6587). All other mutations examined lack the virus. Reversions of Myo5ad to wild-type, which have been reported frequently, are caused by excision of the virusleaving exactly one long terminal repeat in place (J:7092). The virus is integrated into a noncoding region of the DNA (J:7751). | ||
Strains carrying Myo5ad allele
001005 AKXD1/TyJ 001003 AKXD11/TyJ 000765 AKXD13/TyJ 000779 AKXD14/TyJ 000954 AKXD15/TyJ 001093 AKXD18/TyJ 000776 AKXD2/TyJ 001062 AKXD21/TyJ 000947 AKXD22/TyJ 000949 AKXD25/TyJ 000764 AKXD27/TyJ 000959 AKXD3/TyJ 000285 B6.Cg-Rorasg + +/+ Myo5ad Bmp5se/J 000652 BDP/J 000036 BXD1/TyJ 000013 BXD16/TyJ 000015 BXD18/TyJ 000010 BXD19/TyJ 000077 BXD21/TyJ 000043 BXD22/TyJ 000081 BXD25/TyJ 006255 BXD25/TyJRwwJ 000029 BXD29/TyJ 000037 BXD5/TyJ 000007 BXD6/TyJ 000084 BXD8/TyJ 000105 BXD9/TyJ 000284 CWD/LeJ 000670 DBA/1J 000671 DBA/2J 000963 DBA/2J-Myo5ad+17J/Myo5ad/J 000964 DBA/2J-Myo5ad+18J/Myo5ad/J 000067 DBA/2J-Myo5ad+2J/Myo5ad/J 000673 HRS/J 000674 I/LnJ 001850 MEV-Q/TyJ 001855 MEV-V/TyJ 003345 MEV/2Ty-Emv64/J 000679 P/J 000644 SEA/GnJ 000994 STOCK a Myo5ad Mregdsu/J 000286 STOCK a/a Myo5ad fd/+ +/J View Strains carrying Myo5ad (42 strains)
Strains carrying other alleles of Myo5a
005012 A.B6 Tyr+-Myo5ad-l31J/J 001013 B10.D2/nSnJ-Myo5ad-n/J 000502 B6 x B6CBCa Aw-J/A-Myo5aflr Gnb5flr/J 000963 DBA/2J-Myo5ad+17J/Myo5ad/J 000964 DBA/2J-Myo5ad+18J/Myo5ad/J 000067 DBA/2J-Myo5ad+2J/Myo5ad/J 000253 DLS/LeJ View Strains carrying other alleles of Myo5a (7 strains)
Ds related
Myo5ad relatedDevelopmental Biology Research
Embryonic Lethality (Homozygous)
Dermatology Research
Color and White Spotting Defects
Mouse/Human Gene Homologs
Griscelli Syndrome
| Strain Name: | STOCK Myo5ad Ds/J |
| Stock Number: | 000390 |
IMPORTANT NOTE: Prices are based on shipping destination. To view prices, select your shipping destination.
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
Cryorecovery - Standard. The recovery process begins when a signed agreement form is returned to the Customer Service Department after order placement. Although results vary by strain, at least two males and two females (two pairs) will be provided, typically within 15 weeks of our receipt of the signed agreement form. If the first recovery attempt is unsuccessful or only one pair is recovered, a second recovery will be done, extending the delivery time to approximately 25 weeks. At least one member of each pair will be of known genotype and will carry the mutation if it is a mutant strain. Please note that pairs may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation of the strain. Mating schemes are sometimes modified for successful cryopreservation. Price represents a repository maintenance fee, which includes the cost of recovery of the strain from the cryopreservation resource and the periodic replacement of the frozen embryos used for recovery. Cryorecovery to establish a Dedicated Supply for greater quantities of mice. |
| Licensing | See General Terms and Conditions below |
| Control Information | View Control Information in Strain Details. |
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form